Tralokinumab in the Era of Disruption in Atopic Dermatitis
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
tralokinumab is being evaluated for use in atopic dermatitis, with one study focusing on its use in children. however, it appears that another medication, lebrikizumab, is also being tested for the same condition. the status of tralokinumab's development and its relationship to lebrikizumab is unclear.